Fermenta Biotech Ltd Stock Price Today (NSE: FERMENTA)
Fundamental Score
Fermenta Biotech Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Fermenta Biotech Ltd share price today is ₹319.05, down 4.70% on NSE/BSE as of 30 March 2026. Fermenta Biotech Ltd (FERMENTA) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹818.18 (Cr). The 52-week high for FERMENTA share price is ₹399.00 and the 52-week low is ₹241.30. At a P/E ratio of 7.30x, FERMENTA is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 24.88% and a debt-to-equity ratio of 0.29.
Fermenta Biotech Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Fermenta Biotech Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Fermenta Biotech Share Price: A Deep Dive
The pharmaceutical sector is currently witnessing a surge in demand for specialized Active Pharmaceutical Ingredients (APIs), driven by increasing healthcare awareness and a global shift towards preventive medicine. This analysis examines the "Fermenta Biotech share price," currently at ₹328.25, through a financial lens, considering its valuation and competitive positioning. This assessment is part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra.
Fermenta Biotech's current Price-to-Earnings (PE) ratio of 7.3 presents a potentially undervalued scenario when viewed in the context of the broader pharmaceutical landscape. For context, consider
Mankind Pharma Ltd. While Mankind Pharma, a significant player in the Indian market, commands a higher PE ratio, its strengths are rooted in brand recognition and distribution networks, potentially reflecting differing investor perceptions of management quality and risk profiles. Fermenta Biotech appears to focus on specific niche manufacturing.A key factor contributing to Fermenta Biotech's potential competitive advantage is its robust Return on Capital Employed (ROCE) of 22.97%. This signifies the company's effectiveness in generating profits from its capital investments. A high ROCE strengthens the company's economic moat, making it more difficult for competitors to erode its profitability. This superior capital allocation allows Fermenta Biotech to reinvest in research and development, expand its product portfolio, and potentially acquire smaller players.
However, it's crucial to consider the limitations of relying solely on PE and ROCE. Comparing Fermenta Biotech with peers like Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd requires a deeper understanding of their respective product mixes, geographical reach, and regulatory environments. A thorough analysis of cash flow generation, debt levels, and management's strategic vision is essential to form a well-rounded perspective on the long-term prospects of Fermenta Biotech. This analysis offers an observational perspective and should not be construed as investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Fermenta Biotech Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of FERMENTA across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (24.88%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (22.97%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (15.97%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 7.30 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (65.91%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (37.03%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.29)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (11.15x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹213.64 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (64.09%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Limited Institutional Interest (FII+DII: 0.02%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Fermenta Biotech Ltd Financial Statements
Comprehensive financial data for Fermenta Biotech Ltd including income statement, balance sheet and cash flow
About FERMENTA (Fermenta Biotech Ltd)
Fermenta Biotech Ltd is a dynamic pharmaceutical company carving a niche for itself in the global landscape. Beyond its core function of manufacturing, Fermenta Biotech actively cu...ltivates innovative solutions for a healthier future. It's not just about churning out drugs, but about strategically developing and marketing a diverse portfolio of chemical compounds, high-quality bulk drug substances, and specialized enzymes, all meticulously crafted to meet stringent international standards. This dedication extends beyond human health, encompassing environmental solutions designed to promote sustainability and responsible practices within the industry. With a commitment to research and development, Fermenta is continuously exploring new frontiers in biotechnology, aiming to deliver impactful products that improve quality of life. Fermenta Biotech’s influence expands beyond the laboratory, reaching into the realms of health and wellness through education and community engagement. Recognizing the importance of preventative care, the company actively supports initiatives aimed at raising health awareness and promoting healthy lifestyles. This holistic approach reflects a dedication to improving the well-being of individuals and communities. Furthermore, Fermenta Biotech showcases a smart business acumen by strategically managing property assets, indicating a financially sound approach to long-term sustainability and growth. This blend of scientific innovation, responsible environmental practices, and shrewd business decisions positions Fermenta as a forward-thinking player in the pharmaceutical sector. Central to Fermenta Biotech's product offerings is a diverse range of Vitamin D3 variants, carefully formulated to address the specific needs of various industries. From crystalline oil for pharmaceutical applications to feed-grade powder for animal nutrition, the company leverages its expertise in biotechnology to deliver tailored solutions. These products are rigorously tested and manufactured under strict quality control measures, ensuring efficacy and safety for consumers. The company's continuous investment in research and development reflects its commitment to staying at the forefront of innovation and providing high-quality products that contribute to improved health outcomes and nutritional well-being across diverse sectors.
Company Details
Key Leadership
Corporate Events
Latest News
FERMENTA Share Price: Frequently Asked Questions
What is the current share price of Fermenta Biotech Ltd (FERMENTA)?
As of 30 Mar 2026, 12:02 pm IST, Fermenta Biotech Ltd share price is ₹319.05. The FERMENTA stock has a market capitalisation of ₹818.18 (Cr) on NSE/BSE.
Is FERMENTA share price Overvalued or Undervalued?
FERMENTA share price is currently trading at a P/E ratio of 7.30x, compared to the industry average of 31.77x. Based on this relative valuation, the Fermenta Biotech Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of FERMENTA share price?
The 52-week high of FERMENTA share price is ₹399.00 and the 52-week low is ₹241.30. These values are updated daily from NSE/BSE price data.
What factors affect the Fermenta Biotech Ltd share price?
Key factors influencing FERMENTA share price include quarterly earnings growth (Sales Growth: 37.03%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Fermenta Biotech Ltd a good stock for long-term investment?
Fermenta Biotech Ltd shows a 5-year Profit Growth of 7.00% and an ROE of 24.88%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.29 before investing in FERMENTA shares.
How does Fermenta Biotech Ltd compare with its industry peers?
Fermenta Biotech Ltd competes with major peers in the Pharmaceuticals. Investors should compare FERMENTA share price P/E of 7.30x and ROE of 24.88% against the industry averages to determine competitive standing.
What is the P/E ratio of FERMENTA and what does it mean?
FERMENTA share price has a P/E ratio of 7.30x compared to the industry average of 31.77x. Investors pay ₹7 for every ₹1 of annual earnings.
How is FERMENTA performing according to Bull Run's analysis?
FERMENTA has a Bull Run fundamental score of 67.5/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does FERMENTA belong to?
FERMENTA operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Fermenta Biotech Ltd share price.
What is Return on Equity (ROE) and why is it important for FERMENTA?
FERMENTA has an ROE of 24.88%, which indicates excellent management efficiency. ROE measures how efficiently Fermenta Biotech Ltd generates profits from shareholders capital.
How is FERMENTA debt-to-equity ratio and what does it indicate?
FERMENTA has a debt-to-equity ratio of 0.29, which indicates conservative financing with low financial risk.
What is FERMENTA dividend yield and is it a good dividend stock?
FERMENTA offers a dividend yield of 0.90%, meaning you receive ₹0.90 annual dividend for every ₹100 invested in Fermenta Biotech Ltd shares.
How has FERMENTA share price grown over the past 5 years?
FERMENTA has achieved 5-year growth rates of: Sales Growth 9.89%, Profit Growth 7.00%, and EPS Growth 7.00%.
What is the promoter holding in FERMENTA and why does it matter?
Promoters hold 64.09% of FERMENTA shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Fermenta Biotech Ltd.
What is FERMENTA market capitalisation category?
FERMENTA has a market capitalisation of ₹818 crores, placing it in the Small-cap category.
How volatile is FERMENTA stock?
FERMENTA has a beta of N/A. A beta > 1 suggests the Fermenta Biotech Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is FERMENTA operating profit margin trend?
FERMENTA has a 5-year average Operating Profit Margin (OPM) of 15.97%, indicating the company's operational efficiency.
How is FERMENTA quarterly performance?
Recent quarterly performance shows Fermenta Biotech Ltd YoY Sales Growth of 37.03% and YoY Profit Growth of 65.91%.
What is the institutional holding pattern in FERMENTA?
FERMENTA has FII holding of 0.02% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Fermenta Biotech Ltd stock.